Legal Opinion
Glycobiosciences, Inc. v. Innocutis Holdings, LLC
District Court, District of Columbia
Decided May 24, 2016No. Civil Action No. 2012-1901PublishedCited by 11 opinions
1Opinion of the Court
MEMORANDUM OPINION AND ORDER
RANDOLPH D. MOSS, United States District Judge
Presently before the Court is the motion of Defendant Fidia Farmaceutici S.P.A. (“Fidia”) to dismiss portions of Plaintiff Glycobiosciences’s (“Glyco”) amended complaint. See Dkt. 85. Fidia moves to dismiss Glyco’s claims for misappropriation of trade secrets in violation of D.C. Code § 36-401 et seq. (Count IV); unlawful trade practices in violation of the District of Columbia Consumer Protection Procedures Act, D.C. Code § 28-3901 et seq. (Count V); common law unfair competition (Count VI); and unjust enrichment…
2Cases cited24 opinions
- Hishon v. King & SpaldingSupreme Court of the United States · 1984
- Atlantic Marine Constr. Co. v. United States Dist. Court for Western Dist. of Tex.Supreme Court of the United States · 2013
- The Bremen v. Zapata Off-Shore Co.Supreme Court of the United States · 1972
- Stewart Organization, Inc. v. Ricoh Corp.Supreme Court of the United States · 1988
- Citizens United v. Federal Election CommissionSupreme Court of the United States · 2010
19 more not listed; retrieve them via the Exa API.
3Cited by11 opinions
- Azima v. Rak Inv. Auth.Court of Appeals for the D.C. Circuit · 2018
- D & S Consulting, Inc. v. Kingdom of Saudi ArabiaCourt of Appeals for the D.C. Circuit · 2018
- Revis v. Tustin Constr. Servs., LLCCourt of Appeals for the D.C. Circuit · 2018
- Billard Ex Rel. Liquidity Services, Inc. v. AngrickDistrict Court, District of Columbia · 2016
- Azima v. Rak Investment AuthorityDistrict Court, District of Columbia · 2018
6 more not listed; retrieve them via the Exa API.